MEDPROFIT, OOO, Saint Petersburg

Economic indicators

Net profit (RAS) of MEDPROFIT, OOO grew over 2023 by 49.36% to 823.00 thousand RUB from 551.00 thousand RUB over 2022, the company informed.

Revenue increased in the accounting period by 3.42% to 26.57 million RUB from 25.70 million RUB over 2022.

Net profit (RAS) of MEDPROFIT, OOO dropped in 2022 by 22.50% to 551.00 thousand RUB from 711.00 thousand RUB over the same period in 2021, the company informed.

Revenue decreased in the accounting period by 38.97% to 25.70 million RUB from 42.10 million RUB in 2021.

Net profit (RAS) of MEDPROFIT, OOO dropped in 2021 by 34.29% to 711.00 thousand RUB from 1.08 million RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period 2.28 times to 42.10 million RUB from 18.45 million RUB over 2020.

Net profit (RAS) of MEDPROFIT, OOO dropped in 2020 by 15.60% to 1.08 million RUB from 1.28 million RUB over the same period in 2019, the company informed.

Revenue increased in the accounting period by 43.94% to 18.45 million RUB from 12.82 million RUB over 2019.

Net profit (RAS) of MEDPROFIT, OOO made up 152.00 thousand RUB over 2018 compared to net loss of 2.71 million RUB over 2017, the company informed.

Revenue increased in the accounting period 2.79 times to 9.11 million RUB from 3.27 million RUB over 2017; cost of goods sold grew by 49.10% to 8.87 million RUB from 5.95 million RUB; sales profit made up 244.00 thousand RUB compared to sales loss of 2.68 million RUB.

Net loss (RAS) of MEDPROFIT, OOO increased 4.64 times to 2.71 million RUB from 584.00 thousand RUB over 2016, the company informed.

Cost of goods sold grew 10.18 times to 5.95 million RUB from 584.00 thousand RUB; sales loss grew 4.58 times to 2.68 million RUB from 584.00 thousand RUB.

Companies in the region

• AVTOSPETS
• NPK
• MONOLITINVEST NEVA
• PF GARANT
• STS DORS